ADMA Biologics (ADMA) Soars 11.6% as Firm Denies Short Seller Allegations
ADMA Biologics snapped a five-day losing streak on Friday, soaring 11.58 percent to finish at $9.25 apiece after debunking a short seller report that criticized the company for allegedly issuing misleading...







